Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study

In patients with multiple myeloma (MM), SARS-CoV-2 infection has been associated with a severe clinical course and high mortality rates due to the concomitant disease- and treatment-related immunosuppression. Specific antiviral treatment involves viral replication control with monoclonal antibodies...

全面介紹

書目詳細資料

Principais autores:	Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios A. Dimopoulos, Evangelos Terpos
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2023-03-01
叢編:	Viruses
主題:	multiple myeloma molnupiravir ritonavir-nirmatrelvir SARS-CoV-2 belantamab mafodotin
在線閱讀:	https://www.mdpi.com/1999-4915/15/3/704
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!